FREM1 and breast neoplasm: Moreover, the patients with elderly age, advanced clinical stage and distant metastases exhibited dramatically lower expression of FREM1, heralding the possibility of becoming a more aggressive phenotype for breast tumors with aberrant reduced FREM1 expression.